ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 H44.2A2

Billable / Specific

Degenerative myopia with choroidal neovascularization, left eye

H44
Block
0
Synonyms
80
LCDs
16
Payer Policies
0
Linked CPTs

About ICD-10-CM H44.2A2

ICD-10-CM code H44.2A2 represents Degenerative myopia with choroidal neovascularization, left eye. This is a billable/specific code in the Eye and Adnexa chapter (block H44). The 2026 edition of ICD-10-CM H44.2A2 became effective on October 1, 2025.

Medicare LCD Coverage for H44.2A2

Local Coverage Determinations (LCDs) from CMS MACs that list H44.2A2 as a covered diagnosis.

80 LCDs

Showing top 10 of 80 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Article ID: 53060, Effective: 2025-10-01 00:00:00, 1692 covered, 0 non-covered
CPT 92201 →
CMS LCD: Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Article ID: 53060, Effective: 2025-10-01 00:00:00, 1692 covered, 0 non-covered
CPT 92250 →
CMS LCD: Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Article ID: 53060, Effective: 2025-10-01 00:00:00, 1692 covered, 0 non-covered
CPT 92202 →
CMS LCD: Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Article ID: 53060, Effective: 2025-10-01 00:00:00, 1692 covered, 0 non-covered
CPT 92227 →
CMS LCD: Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Article ID: 53060, Effective: 2025-10-01 00:00:00, 1692 covered, 0 non-covered
CPT 92228 →
CMS LCD: Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�aflibercept-yszy and YESAFILI� aflibercept-jbvf
Article ID: 52451, Effective: 2026-01-01 00:00:00, 230 covered, 0 non-covered
CPT Q5147 →
CMS LCD: Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�aflibercept-yszy and YESAFILI� aflibercept-jbvf
Article ID: 52451, Effective: 2026-01-01 00:00:00, 230 covered, 0 non-covered
CPT Q5124 →
CMS LCD: Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�aflibercept-yszy and YESAFILI� aflibercept-jbvf
Article ID: 52451, Effective: 2026-01-01 00:00:00, 230 covered, 0 non-covered
CPT Q5150 →
CMS LCD: Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�aflibercept-yszy and YESAFILI� aflibercept-jbvf
Article ID: 52451, Effective: 2026-01-01 00:00:00, 230 covered, 0 non-covered
CPT J0177 →
CMS LCD: Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�aflibercept-yszy and YESAFILI� aflibercept-jbvf
Article ID: 52451, Effective: 2026-01-01 00:00:00, 230 covered, 0 non-covered
CPT 67027 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing H44.2A2.

16 policies

5 Medicare

Billing and Coding: Bevacizumab and biosimilars
Policy ID: ART-52370
Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU�aflibercept-ayyh, AHZANTIVE�aflibercept-abzv. ENZEEVU�aflibercept-mrbb, OPUVIZ�a
Policy ID: ART-52451
Billing and Coding: Intraocular Bevacizumab
Policy ID: ART-53008
Billing and Coding: Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
Policy ID: ART-53060
Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
Policy ID: ART-56537

CPT Codes Commonly Billed with H44.2A2

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for H44.2A2

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

ICD-10 H44.2A2, Billing FAQ

Is ICD-10 code H44.2A2 billable? +

Yes, H44.2A2 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on June 1, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included